Impact of Vitamin D Supplementation on Recurrent Respiratory Infections in Paediatric Primary Care.
Status:
Completed
Trial end date:
2015-11-01
Target enrollment:
Participant gender:
Summary
Up to date, some clinical trial have evaluated the efficacy and safety of Vitamin D
supplementation in children with RRI, with no conclusive information.
Therefore, the investigators designed a prospective, single-blind, clinical trial to evaluate
whether oral supplementation with vitamin D from October to April reduces the global health
burden of recurrent respiratory tract infections in a primary care setting.
The primary outcome was evaluated if Vitamin D supplementation during autumn and winter can
reduce the number of respiratory tract infections in children diagnosed with recurrent
respiratory tract infections the seasons before.
Secondary objectives was the assessment of Vitamin D supplementation benefits on global
socioeconomic burden of recurrent respiratory tract infections in a primary care setting,
according to number of visits to the primary care paediatrician and use of antibiotics due to
respiratory tract infections.
Phase:
Phase 4
Details
Lead Sponsor:
Policlinico Hospital
Treatments:
Cholecalciferol Ergocalciferols Vitamin D Vitamins